febuxostat has been researched along with raloxifene hydrochloride in 1 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (raloxifene hydrochloride) | Trials (raloxifene hydrochloride) | Recent Studies (post-2010) (raloxifene hydrochloride) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 2,818 | 481 | 810 |
| Protein | Taxonomy | febuxostat (IC50) | raloxifene hydrochloride (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.0053 | |
| Gastric inhibitory polypeptide receptor | Homo sapiens (human) | 0.0004 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.1297 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adusumalli, S; Akhlaghi, F; Jamwal, R; Leggio, L; Obach, RS; Ryder, TF | 1 |
1 trial(s) available for febuxostat and raloxifene hydrochloride
| Article | Year |
|---|---|
Role of Molybdenum-Containing Enzymes in the Biotransformation of the Novel Ghrelin Receptor Inverse Agonist PF-5190457: A Reverse Translational Bed-to-Bench Approach.
Topics: Administration, Oral; Alcoholism; Aldehyde Oxidase; Animals; Azetidines; Biotransformation; Cytosol; Febuxostat; Female; Ghrelin; Hepatocytes; Humans; Liver; Mice; Microsomes, Liver; Molybdenum; Raloxifene Hydrochloride; Receptors, Ghrelin; Spiro Compounds; Xanthine Oxidase | 2019 |